SARS-CoV-2
ELISA, Neutralization
Human
IgG1, kappa
C102
SARS-CoV-2
ELISA, Neutralization
Human
IgG1, kappa
C105
SARS-CoV-2
Neutralization
Human
IgG1, kappa
1H1
SARS-CoV-2
Neutralization
Human
IgG1, kappa
5E1#
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Neutralization
Human
IgG1, kappa
S41
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization, IF
Human
IgG1, kappa
D12
Human betacoronavirus 2c EMC/2012
ELISA, Neutralization
Human
IgG1, kappa
4C2
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization
Human
IgG1
JC57-14
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization
Human
IgG1
CDC2-C2
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization, IF
Human
IgG1
MCA1